Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26823621
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Hosp+Pharm
2015 ; 50
(8
): 714-27
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Secukinumab
#MMPMID26823621
Cada DJ
; Baker DE
; Panther SG
; PharmD KI
Hosp Pharm
2015[Sep]; 50
(8
): 714-27
PMID26823621
show ga
Each month, subscribers to The Formulary Monograph Service receive 5 to 6
well-documented monographs on drugs that are newly released or are in late phase
3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees.
Subscribers also receive monthly 1-page summary monographs on agents that are
useful for agendas and pharmacy/nursing in-services. A comprehensive target drug
utilization evaluation/medication use evaluation (DUE/MUE) is also provided each
month. With a subscription, the monographs are sent in print and are also
available on-line. Monographs can be customized to meet the needs of a facility.
A drug class review is now published monthly with The Formulary Monograph
Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes
selected reviews in this column. For more information about The Formulary
Monograph Service, call The Formulary at 800-322-4349. The September 2015
monograph topics are cangrelor, lumacaftor/ivacaftor, brexpiprazole, talimogene
laherparepvec, and lesinurad. The Safety MUE is on cangrelor.
free
free
free
